Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

AMS:CCEP - Euronext Amsterdam - GB00BDCPN049 - Common Stock - Currency: EUR

81.3  -0.3 (-0.37%)

Fundamental Rating

4

CCEP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 25 industry peers in the Beverages industry. There are concerns on the financial health of CCEP while its profitability can be described as average. While showing a medium growth rate, CCEP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
In the past year CCEP had a positive cash flow from operations.
Each year in the past 5 years CCEP has been profitable.
In the past 5 years CCEP always reported a positive cash flow from operatings.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

CCEP has a Return On Assets of 4.56%. This is in the better half of the industry: CCEP outperforms 72.00% of its industry peers.
Looking at the Return On Equity, with a value of 16.70%, CCEP is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Return On Invested Capital of CCEP (7.00%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CCEP is in line with the industry average of 7.84%.
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROIC 7%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Profit Margin of CCEP (6.94%) is comparable to the rest of the industry.
CCEP's Profit Margin has declined in the last couple of years.
The Operating Margin of CCEP (10.46%) is worse than 72.00% of its industry peers.
CCEP's Operating Margin has declined in the last couple of years.
CCEP's Gross Margin of 35.31% is on the low side compared to the rest of the industry. CCEP is outperformed by 80.00% of its industry peers.
In the last couple of years the Gross Margin of CCEP has remained more or less at the same level.
Industry RankSector Rank
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

CCEP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CCEP has been increased compared to 1 year ago.
The number of shares outstanding for CCEP has been increased compared to 5 years ago.
CCEP has a better debt/assets ratio than last year.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.19. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
CCEP's Altman-Z score of 2.19 is in line compared to the rest of the industry. CCEP outperforms 60.00% of its industry peers.
The Debt to FCF ratio of CCEP is 5.34, which is a neutral value as it means it would take CCEP, 5.34 years of fcf income to pay off all of its debts.
CCEP has a better Debt to FCF ratio (5.34) than 88.00% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that CCEP has dependencies on debt financing.
CCEP has a worse Debt to Equity ratio (1.17) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Altman-Z 2.19
ROIC/WACC0.94
WACC7.47%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP has a Current ratio of 0.81. This is in the lower half of the industry: CCEP underperforms 68.00% of its industry peers.
A Quick Ratio of 0.62 indicates that CCEP may have some problems paying its short term obligations.
CCEP has a Quick ratio (0.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.62
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

CCEP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.31%.
The Earnings Per Share has been growing slightly by 5.80% on average over the past years.
CCEP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.67%.
CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%

3.2 Future

Based on estimates for the next years, CCEP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.28% on average per year.
CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.08% yearly.
EPS Next Y5.49%
EPS Next 2Y7.39%
EPS Next 3Y7.9%
EPS Next 5Y9.28%
Revenue Next Year3.24%
Revenue Next 2Y3.41%
Revenue Next 3Y3.58%
Revenue Next 5Y3.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CCEP is valuated quite expensively with a Price/Earnings ratio of 26.48.
Based on the Price/Earnings ratio, CCEP is valued a bit more expensive than 68.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CCEP is valued at the same level.
The Price/Forward Earnings ratio is 19.23, which indicates a rather expensive current valuation of CCEP.
Based on the Price/Forward Earnings ratio, CCEP is valued a bit more expensive than 68.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CCEP is around the same levels.
Industry RankSector Rank
PE 26.48
Fwd PE 19.23
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCEP is valued more expensive than 80.00% of the companies in the same industry.
64.00% of the companies in the same industry are more expensive than CCEP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.64
EV/EBITDA 15.31
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.82
PEG (5Y)4.56
EPS Next 2Y7.39%
EPS Next 3Y7.9%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.32%, CCEP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.92, CCEP is paying slightly less dividend.
CCEP's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

The dividend of CCEP is nicely growing with an annual growth rate of 9.91%!
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

64.17% of the earnings are spent on dividend by CCEP. This is not a sustainable payout ratio.
The dividend of CCEP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP64.17%
EPS Next 2Y7.39%
EPS Next 3Y7.9%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

More info and screens

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (7/11/2025, 7:00:00 PM)

81.3

-0.3 (-0.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-29 2025-04-29
Earnings (Next)N/A N/A
Inst Owners37.53%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap37.42B
Analysts77.27
Price Target83.87 (3.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP64.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.05%
PT rev (3m)-2.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.97%
Valuation
Industry RankSector Rank
PE 26.48
Fwd PE 19.23
P/S 1.83
P/FCF 17.64
P/OCF 12.23
P/B 4.41
P/tB N/A
EV/EBITDA 15.31
EPS(TTM)3.07
EY3.78%
EPS(NY)4.23
Fwd EY5.2%
FCF(TTM)4.61
FCFY5.67%
OCF(TTM)6.65
OCFY8.18%
SpS44.4
BVpS18.44
TBVpS-19.44
PEG (NY)4.82
PEG (5Y)4.56
Profitability
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROCE 9.32%
ROIC 7%
ROICexc 7.57%
ROICexgc 42.27%
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
FCFM 10.38%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Debt/EBITDA 3.24
Cap/Depr 100.64%
Cap/Sales 4.59%
Interest Coverage 8.59
Cash Conversion 99.67%
Profit Quality 149.65%
Current Ratio 0.81
Quick Ratio 0.62
Altman-Z 2.19
F-Score5
WACC7.47%
ROIC/WACC0.94
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
EPS Next Y5.49%
EPS Next 2Y7.39%
EPS Next 3Y7.9%
EPS Next 5Y9.28%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%
Revenue Next Year3.24%
Revenue Next 2Y3.41%
Revenue Next 3Y3.58%
Revenue Next 5Y3.08%
EBIT growth 1Y-4.98%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.62%
EBIT Next 3Y17.56%
EBIT Next 5Y12.75%
FCF growth 1Y6.42%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y9.09%
OCF growth 3Y13.08%
OCF growth 5Y9.96%